Evaluation of Topical Sodium Valproate-Loaded Nano Spanlastics Formulation Versus Minoxidil 5% in the Treatment of Female Pattern Hair Loss Using Transdermal Delivery: A Comparative Study
January 2023
in “The Egyptian Journal of Hospital Medicine”
TLDR Topical Valproic acid and 5% Minoxidil both significantly increase hair count in Female Pattern Hair Loss, with similar side effects.
The study evaluated the effectiveness of topical Valproic acid (VPA) and 5% topical minoxidil in treating Female Pattern Hair Loss (FPHL). It included 81 patients with FPHL, divided into three groups: 27 treated with topical sodium valproate-loaded nano spanlastics formulation, 27 treated with minoxidil® 5% lotion, and 27 treated with saline using transdermal delivery for 6 months. The results showed that both VPA and minoxidil significantly increased the total hair count compared to the control group (P = 0.047). Adverse events were moderate and self-limiting in both groups, with comparable prevalence rates (P = 0.72). The study concluded that topical VPA is a potential therapy option for FPHL.
View this study on ejhm.journals.ekb.eg →
Related
research Pediatric Androgenetic Alopecia: An Updated Review
research Effectiveness of Multimodality Therapy Using Minoxidil and Microneedling for the Treatment of Alopecia: A Systematic Review and Meta-Analysis
research Evaluation of Topical Sodium Valproate-Loaded Nano Spanlastics Formulation Versus Minoxidil 5% in the Treatment of Female Pattern Hair Loss Using Transdermal Delivery: A Comparative Study
Topical Valproic acid and 5% Minoxidil both significantly increase hair count in Female Pattern Hair Loss, with similar side effects.
research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil
A study explored the treatment of Sisaipho alopecia areata, a rare variant of AA characterized by hair loss on the top of the scalp while sparing the temporal and occipital areas, using tofacitinib and oral minoxidil. The combination of these treatments showed promise in managing this challenging condition, which typically presents as nonscarring hair loss and can be difficult to treat.
research A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss
Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.
research Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
Using minoxidil and tofacitinib together can effectively treat severe hair loss.
research The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
research The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review
Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.
research Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment
Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.